Avacta Group Plc (LON:AVCT – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 57.67 ($0.72) and traded as low as GBX 45.68 ($0.57). Avacta Group shares last traded at GBX 48 ($0.60), with a volume of 1,320,100 shares.
Avacta Group Stock Down 0.5 %
The company has a market capitalization of £171.09 million, a price-to-earnings ratio of -530.56 and a beta of 1.12. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96. The firm’s fifty day moving average price is GBX 50.63 and its 200-day moving average price is GBX 57.71.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Further Reading
- Five stocks we like better than Avacta Group
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to invest in marijuana stocks in 7 steps
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- What Are Dividend Challengers?
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
